Physician profile
Davis Reames
NPI 1467656728
$2,109.30
in general payments reported to CMS, 2019-2025
17 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $817 · 2021: $95.97 · 2022: $159 · 2023: $75.34 · 2024: $193 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirus, LLC | $746.10 | 2020 | |
| Alphatec Spine, INC | $426.05 | 2019 | |
| Boston Scientific Corporation | $273.74 | 2021-2024 | |
| Nuvasive, INC. | $247.65 | 2019-2022 | |
| Medtronic, INC. | $90.56 | 2021-2025 | Strata, Kyphon Express II Kyphopak Tray |
| Arbor Pharmaceuticals, INC. | $67.40 | 2019 | |
| Ossdsign USA Incorporated | $39.42 | 2025 | Ossdsign Catalyst |
| Nanohive Medical LLC | $37.27 | 2025 | Csa, Alif Sa |
| Novocure INC. | $32.18 | 2022 | |
| Nevro Corp. | $23.13 | 2024 | Senza |
| Depuy Synthes Sales INC. | $20.87 | 2023 | Viper |
| Stryker Corporation | $20.84 | 2022 | |
| Radius Health, INC. | $19.24 | 2021 | |
| Intrinsic Therapeutics | $17.94 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.16 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $15.65 | 2023 | Direct Look |
| Medtronic USA, INC. | $15.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davis Reames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.